Next Generation Diabetes Therapy and Drug Delivery Market size was valued at $7.1 billion in 2020, and is estimated to reach $28.0 billion by 2030, growing at a CAGR of 14.28% from 2021 to 2030.ย ย Next generation diabetes therapy and drug delivery devices are used to check the blood glucose levels and deliver insulin into the body. Next generation diabetes drug delivery systems, such as oral and inhalable insulin, help introduce insulin into the patientโs body without causing pain and reduce the risk of skin irritation owing to frequent use of needles. Advancements in diabetes therapy systems, such as insulin patch, continuous glucose monitoring (CGM) system, and artificial pancreas, are frequently used to detect the glucose levels and adjust the insulin levels to manage the change in glucose levels.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/2098
๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐ฆ๐ฐ๐ฒ๐ป๐ฎ๐ฟ๐ถ๐ผ:
COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. The Next Generation Diabetes Therapy Marketย alsoย declined in 2020 due to factors such as a decline in diabetes services, reduced access to specialists, treatment interruption, delays and disruption in clinical trials and disrupted supply chain and challenges. However, the market is anticipated to witness recovery in 2021, and show stable growth for next generation diabetes therapy and drug delivery market in the coming future.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/2098
On the basis of demographic, the market is classified into adult population (>14 years) and child population (โค14 years). The adult population segment dominated the global market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to increase in prevalence of diabetes in adult population due to unhealthy lifestyle.
On the basis of indication, the market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment dominated the global market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to increase in cases of type-2 diabetic due to increase in urbanization, unhealthy diet, and reduced physical activity.
By end user, the market is segregated into diagnostics/clinics, ICUs, and home healthcare. The diagnostics/clinics dominated the global market in 2020, and is anticipated to continue this trend during the forecast period, owing to increase in procurement of the products from diagnostics and clinics by diabetic patients.
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- On the basis of product, the CGM system held largest share in the global market in 2020.
- On the basis of demographic, the adult population held the largest market share in 2020 and is expected to remain dominant during the forecast period.
- On the basis of indication, the type-2 diabetes segment held the largest share in the global market in 2020
- By end user, the diagnostic/clinics segment held the largest market share in 2020 and is anticipated to continue this trend during the forecast period.
- Region-wise, North America is expected to experience growth at the highest rate, registering a CAGR of 13.23% during the forecast period.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com